AURA: Aura Biosciences, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-10-01 | New 13G stake | ForGrowth III PA B.V. | 5.10% | SEC | |
| 2026-08-14 | 13G amendment | Frazier Life Sciences Public Fund, L.P. | 5.60% | SEC | |
| 2026-08-14 | New 13G stake | LONG FOCUS CAPITAL MANAGEMENT, LLC | 4.90% | SEC | |
| 2026-08-12 | 13G amendment | Adage Capital Management, L.P. | 8.44% | SEC | |
| 2026-07-27 | Fell below 5% | BlackRock, Inc. | 4.40% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.